Stroke trials in Tanzania
1 of 2 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleStroke Minimization Through Additive Anti-atherosclerotic Agents in Routine Treatment II Study (SMAART II)
- Where
- Dar es Salaam
- Age
- 18 years to 100 years
- People
- 1,000 worldwide
- Run by
- Northern California Institute of Research and Education
See details and how to joinNCT05963568